FORT LAUDERDALE, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS ...
The company reported net income for the fiscal year ending May 31, 2024 of $896,869, with much of this net income due to ...
Tiny Health, a pioneer in at-home microbiome testing for babies and families, announces the addition of two esteemed ...
About The American Macular Degeneration Foundation The American Macular Degeneration Foundation ( macular.org) is a ...
Despite being a flight away, Colleen's quick return home was met with relief as Dr. Alp Sener, Division Head of Urology at ...
KFSHRC attracts international patients by offering specialized cardiology, oncology, neurosciences, organ transplant, and ...
(NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the expanded approval of ...
“We have seen the profound impact this medicine has had for GA patients in the U.S. and remain committed to expanding access to this crucial treatment, focusing on serving unmet patient needs in the U ...
Pending authorization of the Omicron KP.2-adapted vaccine by the EC, both the Omicron KP.2-adapted vaccine and the Omicron JN.1-adapted vaccine will be available across the EU, though availability ...
This new European approval reinforces Ipsen’s commitment to advancing medical innovations to treat people living with rare cholestatic liver diseases ...
Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through ...